Case Presentations in Heart Disease

por Channer, Kevin S.
Publicado 1992

Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34:828–837

por Jones, T. Hugh, Howell, Julian D., Channer, Kevin S.
Publicado 2011

Study protocol to investigate the effects of testosterone therapy as an adjunct to exercise rehabilitation in hypogonadal males with chronic heart failure

por Saxton, John M, Zwierska, Irena, Mathur, Atish, Channer, Kevin S
Publicado 2006

Statin Therapy Is Associated With Lower Total but Not Bioavailable or Free Testosterone in Men With Type 2 Diabetes

por Stanworth, Roger D., Kapoor, Dheeraj, Channer, Kevin S., Jones, T. Hugh
Publicado 2009

Integration between General and Geriatric Medicine: A Needs Related Policy

por McLean, Katharine A, Austin, Christopher A, Neal, Keith R, Channer, Kevin S
Publicado 1994

Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse

por Kelly, Daniel M., Akhtar, Samia, Sellers, Donna J., Muraleedharan, Vakkat, Channer, Kevin S., Jones, T. Hugh
Publicado 2016

Characterization of the vasodilatory action of testosterone in the human pulmonary circulation

por Smith, Alyson M, Bennett, Robert T, Jones, T Hugh, Cowen, Mike E, Channer, Kevin S, Jones, Richard D
Publicado 2008

Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)

por Jones, T. Hugh, Arver, Stefan, Behre, Hermann M., Buvat, Jacques, Meuleman, Eric, Moncada, Ignacio, Morales, Antonio Martin, Volterrani, Maurizio, Yellowlees, Ann, Howell, Julian D., Channer, Kevin S.
Publicado 2011